156 related articles for article (PubMed ID: 36662642)
1. Impact of Age at Diagnosis of Bladder Cancer on Survival: A Surveillance, Epidemiology, and End Results-Based Study 2004-2015.
Lin W; Pan X; Zhang C; Ye B; Song J
Cancer Control; 2023; 30():10732748231152322. PubMed ID: 36662642
[TBL] [Abstract][Full Text] [Related]
2. Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States.
Jazzar U; Yong S; Klaassen Z; Huo J; Hughes BD; Esparza E; Mehta HB; Kim SP; Tyler DS; Freedland SJ; Kamat AM; Wolf DV; Williams SB
Cancer; 2018 Aug; 124(15):3127-3135. PubMed ID: 29660813
[TBL] [Abstract][Full Text] [Related]
3. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
[TBL] [Abstract][Full Text] [Related]
4. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
5. Use of radical cystectomy for patients with invasive bladder cancer.
Gore JL; Litwin MS; Lai J; Yano EM; Madison R; Setodji C; Adams JL; Saigal CS;
J Natl Cancer Inst; 2010 Jun; 102(11):802-11. PubMed ID: 20400716
[TBL] [Abstract][Full Text] [Related]
6. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A;
BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
[TBL] [Abstract][Full Text] [Related]
7. Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference.
Kaye DR; Canner JK; Kates M; Schoenberg MP; Bivalacqua TJ
Bladder Cancer; 2016 Apr; 2(2):225-234. PubMed ID: 27376141
[No Abstract] [Full Text] [Related]
8. Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatment.
Williams SB; Huo J; Dafashy TJ; Ghaffary CK; Baillargeon JG; Morales EE; Kim SP; Kuo YF; Orihuela E; Tyler DS; Freedland SJ; Kamat AM
Urol Oncol; 2017 Oct; 35(10):602.e1-602.e9. PubMed ID: 28647395
[TBL] [Abstract][Full Text] [Related]
9. Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research.
Bekelman JE; Handorf EA; Guzzo T; Evan Pollack C; Christodouleas J; Resnick MJ; Swisher-McClure S; Vaughn D; Ten Have T; Polsky D; Mitra N
Value Health; 2013 Jun; 16(4):610-8. PubMed ID: 23796296
[TBL] [Abstract][Full Text] [Related]
10. Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapy.
Kozak KR; Hamidi M; Manning M; Moody JS
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e197-204. PubMed ID: 22401916
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of bladder neck involvement in non-muscle-invasive bladder cancer: A SEER database analysis with 19,919 patients.
Zhan X; Guo J; Chen L; Deng W; Liu X; Zhu K; Liu W; Fu B
Cancer Med; 2021 Oct; 10(19):6868-6880. PubMed ID: 34423585
[TBL] [Abstract][Full Text] [Related]
12. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis.
Canter D; Egleston B; Wong YN; Smaldone MC; Simhan J; Greenberg RE; Uzzo RG; Kutikov A
Urol Oncol; 2013 Aug; 31(6):866-70. PubMed ID: 21906968
[TBL] [Abstract][Full Text] [Related]
13. Associations Between Female Sex and Treatment Patterns and Outcomes for Muscle-invasive Bladder Cancer.
Grajales V; Bandari J; Hale NE; Yabes JG; Turner RM; Fam MM; Sabik LM; Gingrich JR; Davies BJ; Jacobs BL
Urology; 2021 May; 151():169-175. PubMed ID: 32673679
[TBL] [Abstract][Full Text] [Related]
14. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
[TBL] [Abstract][Full Text] [Related]
15. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer.
Williams SB; Huo J; Chamie K; Hu JC; Giordano SH; Hoffman KE; Dinney CPN; Kamat AM; Shih YT
Eur Urol Focus; 2017 Apr; 3(2-3):258-264. PubMed ID: 28753760
[TBL] [Abstract][Full Text] [Related]
16. Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
Richards KA; Ham S; Cohn JA; Steinberg GD
Int J Urol; 2016 Jan; 23(1):42-7. PubMed ID: 26443388
[TBL] [Abstract][Full Text] [Related]
17. The impact of orthotopic neobladder vs ileal conduit urinary diversion after cystectomy on the survival outcomes in patients with bladder cancer: A propensity score matched analysis.
Su X; Wu K; Wang S; Su W; Li C; Li B; Mao X
Cancer Med; 2020 Oct; 9(20):7590-7600. PubMed ID: 32869540
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.
Mayr R; Gierth M; Zeman F; Reiffen M; Seeger P; Wezel F; Pycha A; Comploj E; Bonatti M; Ritter M; van Rhijn BWG; Burger M; Bolenz C; Fritsche HM; Martini T
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):505-513. PubMed ID: 29479839
[TBL] [Abstract][Full Text] [Related]
19. Persistent muscle-invasive bladder cancer after neoadjuvant chemotherapy: an analysis of Surveillance, Epidemiology and End Results-Medicare data.
Lane G; Risk M; Fan Y; Krishna S; Konety B
BJU Int; 2019 May; 123(5):818-825. PubMed ID: 30126053
[TBL] [Abstract][Full Text] [Related]
20. Nomograms to predict individual prognosis of patients with squamous cell carcinoma of the urinary bladder.
Zhang G; Li Z; Song D; Fang Z
BMC Cancer; 2019 Dec; 19(1):1200. PubMed ID: 31818271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
